Christian Camani

Christian Camani is an experienced investor with a diverse portfolio, actively engaged with multiple companies since 2017. Current roles include investing at Turn2X, Veesion, ONWARD, PathoQuest, Threatray, Attolight, AVAtronics, Biograil™, Wildbiene + Partner, and InterAx Biotech, reflecting a strong commitment to fostering innovation across various sectors. Christian Camani holds a Master of Business Administration (MBA) from the University of St.Gallen, earned between 1987 and 1992.